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Abstract
A number of viral proteases are able to cleave translation initiation factors leading to the inhibition of cellular translation.
This is the case of human immunodeficiency virus type 1 protease (HIV-1 PR), which hydrolyzes eIF4GI and poly(A)-binding
protein (PABP). Here, the effect of HIV-1 PR on cellular and viral protein synthesis has been examined using cell-free systems.
HIV-1 PR strongly hampers translation of pre-existing capped luc mRNAs, particularly when these mRNAs contain a poly(A)
tail. In fact, HIV-1 PR efficiently blocks cap- and poly(A)-dependent translation initiation in HeLa extracts. Addition of
exogenous PABP to HIV-1 PR treated extracts partially restores the translation of polyadenylated luc mRNAs, suggesting that
PABP cleavage is directly involved in the inhibition of poly(A)-dependent translation. In contrast to these data, PABP
cleavage induced by HIV-1 PR has little impact on the translation of polyadenylated encephalomyocarditis virus internal
ribosome entry site (IRES)-containing mRNAs. In this case, the loss of poly(A)-dependent translation is compensated by the
IRES transactivation provided by eIF4G cleavage. Finally, translation of capped and polyadenylated HIV-1 genomic mRNA
takes place in HeLa extracts when eIF4GI and PABP have been cleaved by HIV-1 PR. Together these results suggest that
proteolytic cleavage of eIF4GI and PABP by HIV-1 PR blocks cap- and poly(A)-dependent initiation of translation, leading to
the inhibition of cellular protein synthesis. However, HIV-1 genomic mRNA can be translated under these conditions, giving
rise to the production of Gag polyprotein.
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Introduction
Viruses rely on cellular machinery to synthesize their proteins
since this complex process requires numerous components that
cannotallbe encoded byviralgenomes. Thus, viralmRNAs haveto
compete with host mRNAs for ribosomes and other components of
the translation machinery [1]. To achieve this goal, viruses have
evolved sophisticated mechanisms to maximize the translation of
their mRNAs. Since the initiation of translation is important in the
regulation of gene expression in eukaryotic cells, cytolytic viruses
usually target this step to ensure the synthesis of viral proteins [2]. A
number of viral proteases are involved in the proteolysis of
translation initiation factors, such as eIF4G and PABP [2,3]. Under
these conditions the association of host mRNAs with ribosomes is
severely impaired, whereas viral mRNAs can efficiently interact
with the translation machinery [1,2].
eIF4G mediates the formation of the translation initiation
complex by acting as a scaffold protein that physically links the
40S ribosomal subunit with the mRNA [2,4]. In the canonical
initiation process of translation, the cap structure and the poly(A) tail
of mRNAs are recognized and joined by eIF4E and PABP,
respectively[5,6].In turn, bothproteins interactwiththe N-terminal
portion of eIF4G, which recruits the small ribosomal subunit to the
proximity of the mRNA by the interaction of its C-terminal domain
with eIF3 [2,7]. In addition, eIF4G contains binding sites for other
proteins implicated in translation such as eIF4A and the protein
kinaseMnk1[2].A numberof virusessuchascertain picornaviruses,
retroviruses and caliciviruses, encode proteases which hydrolyze
eIF4G, and separate the domain implicated in mRNA recognition
(N-terminal domain) from the portion involved in the recruitment of
40S ribosomal subunit (C-terminal domain) [1,2,3,8,9]. For
example, the association of host mRNAs and ribosomes is impaired
in poliovirus (PV) infected cells by eIF4G cleavage, while viral
mRNA can interact with the translation machinery by means an
internal ribosome entry site (IRES) placed in its 59 untranslated
region (59 UTR) [10,11]. We previously described that eIF4GI is
cleaved in HIV-1-infected cells, with HIV-1 PR being responsible
for this event [9]. In fact, IRES elements have been identified within
HIV-1, HIV-2, simian immunodeficiency virus and feline immu-
nodeficiencyvirus genomic mRNAs [12,13,14,15].However, little is
known about the regulation of retroviral IRES-driven translation by
cellular and viral factors.
Cleavage of PABP by viral proteases has been described
recently [16,17,18,19,20,21]. PABP binds to the poly(A) tail
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participates in the initiation of translation by linking the poly(A)
tail of mRNAs to eIF4G [5]. The N-terminal domain of PABP
(NTD) contains four RNA recognition motifs (RRM) and the
eIF4G-binding site, while the C-terminal domain (CTD) interacts
with eIF4B and eukaryotic release factor 3 (eRF3) [22,23,24,25]
and regulatory proteins such as PABP-interacting protein 1 and 2
(Paip 1 and 2) [26,27,28], and mediates the oligomerization of
PABP on the poly(A) tail [7]. PV 3C
pro and, to a lesser extent,
2A
pro, cleave PABP separating NTD and CTD [18]. Proteolysis of
PABP by 3C
pro impairs poly(A)-dependent initiation of translation
[19]. Proteases from both human immunodeficiency virus (HIV)-1
and 2 also cleave PABP at two distant positions; one located at the
NTD and CTD junction and another within RRM3 [16]. A
previous work has investigated the effect of PABP cleavage by PV
proteases on protein synthesis [19], but the action of HIV-1 PR on
poly(A)-dependent translation remains unexplored.
The cap structure and poly(A) tail synergistically enhance
translation [2,7]. In this regard, eIF4E and PABP interaction with
eIF4G induces a circular mRNA conformation, which might
enhance ribosome recycling [29]. On the other hand, the
interaction between eIF4G and PABP could induce conforma-
tional changes in the initiation complex in turn increasing the
affinity of eIF4E for the cap structure [30]. Thus, the hydrolysis of
eIF4G or PABP could inhibit the synergism provided by the cap
and poly(A) tail. In this work we analyze the contribution of the
cleavage of eIF4GI and PABP by HIV-1 PR to the inhibition of
translation directed by cap and poly(A) tail of mRNAs in cell-free
systems and their impact on picornavirus IRES-driven translation.
In addition, the effects of HIV-1 PR on the translation of HIV-1
genomic mRNA have been also examined.
Materials and Methods
Plasmid Construction and In Vitro Synthesis of mRNAs
pKS-luc, pTM1-luc and pT59NCP-luc were used as a template
to synthesize luciferase (luc) mRNAs, EMCV and PV IRES-
containing luc mRNA, respectively. These plasmids were described
in previous reports [31,32,33,34]. Human globin 59UTR-contain-
ing luc mRNAs were obtained by in vitro transcription using pKS-
GL-FL as a template. This plasmid was kindly provided by Drs. M.
Hentze and F. Moretti (EMBL, Heidelberg, Germany). The in vitro
transcription was carried out with T7 polymerase (Promega)
according to the indications of the manufacturer and using GpppG
or GpppA (New England Biolabs). In vitro polyadenylation was
performed with poly(A) polymerase (New England Biolabs) and
testedby agarose gel electrophoresis.The mRNA waspurified using
the Chroma spin columns kit (BD Biosciences). The amount of mRNA
was analyzed with the NanoDrop ND-1000 spectrophotometer.
The plasmid pGEX-2T-PABP1 containing the sequence encoding
the human PABP1, lacking the first nine amino acids and fused to
the GST (glutathione S-transferase) gene, was obtained as described
previously [35] and was kindly provided by A. Nieto (Centro
Nacional de Biotecnologı ´a, CSIC, Madrid, Spain). pKS-HIV-1 was
obtained by digestion of pBH10 and pKS plasmid with Sac I,
followed by a treatment with T4 ligase.
In Vitro Translation
The HeLa S3 extracts and the translation reaction mix were
obtained as previously described [36,37,38]. Krebs-2 extracts and
the respective reaction mix were obtained as previously described
[39,40,41]. Nuclease-treated RRL (Promega) was used according to
the manufacturer’s instructions. 20 ng (1.3 ng/ml) of HIV-1 PR or
1 mg (66 ng/ml) of maltose binding protein (MBP)-2A
pro were added
totranslationmixasindicated inthefigurelegends.Proteinsynthesis
was analyzed by metabolic labelling with 50 mCi of [
35S]Met-
[
35S]Cys/ml (Promix; Amersham Biosciences), followed by SDS-
PAGE, fluorography and autoradiography. The samples used to
measure luciferase (Luc) activity were recovered in luciferase lysis
buffer (see below), whereas sample buffer was added to the replicates
to be analyzed by SDS-PAGE followed by Western blotting.
Real-Time RT-PCR
The levels of luc mRNAs in cellular lysates were determined by
real-time quantitative RT-PCR. Total RNA was extracted from in
vitro translation at the times indicated in each figure using the
RNeasy commercial kit (Qiagen), according to the manufacturer’s
recommendations. The primers luc-forward (59 -GAACGAG-
GACGGAGATGTCATCG-39) and luc-reverse (59- GCTCCT-
CTTCTGGTATTCTTGGCG - 39) were used to quantify luc
RNAs with Master SYBR Green I Kit (Roche Diagnostics),
following the protocol previously described [42]. To validate the
results using these primers, real-time RT-PCR using a Taqman
probe designed by Applied Biosystems was carried out as
previously indicated [43]. As a control, 18 S rRNA was measured
using the Hs 99999901-m1 assay (Applied Biosystems). The
amount of the different luc mRNAs was determined by taking into
consideration the 18 S rRNA levels [43]. Data analysis was carried
out with the SDS-7000 software (Version 1.1).
Measurement of Luciferase Activity
Extracts were recovered in a buffer containing 25 mM
glycylglycine (pH 7.8), 0.5% Triton X-100 and 1 mM dithiothre-
itol. Luc activity was determined using luciferase assay system
(Promega) and Mononlight 2010 apparatus (Analytical Lumines-
cence Laboratory) as described previously [8,9].
Immunoblotting
Western blot analysis was carried out using a rabbit antibodies
mix against the N-terminal and C-terminal portion of the
initiation factors eIF4GI [44] and eIF4GII (a generous gift from
N. Sonenberg, McHill University, Montreal, Canada) at 1:1000
dilution. PABP was detected using a monoclonal antibody
(Abcam) at 1:300 dilution or a rabbit polyclonal antibody raised
against GST-PABP at 1:3000 dilution.
Purification of Recombinant Proteins
HIV-1 PR was provided by I. Pichova (Centralized Facility for
AIDS Reagents). The chimeric MBP (maltose-binding protein) and
MBP–2A
pro were purified by affinity chromatography, as described
previously [45]. The pGEX-2T and pGEX- 2T-PABP1 plasmid
was used to purify the GST and GST–PABP1 protein, respectively,
by affinity chromatography, using a glutathione–agarose 4B resin
(Amersham Biosciences) as described previously [35].
Statistical Analysis
Luc activity data and luc RNA levels are presented as mean
values6SD. Differences were tested for significance by means of
the Student t-test. In each experiment, protease treated extracts
were compared with respect to the control. A probability level
P,0.05 was considered significant.
Results
Effect of HIV-1 PR on the Translation of Pre-Existing
Exogenous mRNAs in HeLa Extracts
The cleavage of eIF4GI and PABP by HIV-1 PR has been
recently described [9,16]. Since a circular mRNA conformation,
Translation Blockage by HIV-PR
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enhance ribosome recycling after the termination of translation,
we analyzed the effects of HIV-1 PR on pre-existent capped/non-
polyadenylated (+/2) or capped/polyadenylated (+/+) luc
mRNAs (Figure 1A). As a control, the recombinant protein
MBP tagged to PV 2A
pro (MBP-2A) was also used [45,46]. HeLa
extracts were chosen to carry out this experiment since they
support a strong cap-poly(A) synergism [19]. Tanking into account
the translatability of (+/+), (+/2), uncapped (2/2) and uncapped
polyadenylated (2/+) luc mRNAs (Figure 1A and Figure S1A), we
calculated that the cap-poly(A) synergism supported by our
extracts was of about 5-fold.
Many host mRNAs are engaged in protein synthesis machinery
prior to virus infection. Therefore, these mRNAs must be stripped
from ribosomes to ensure high levels of viral protein synthesis. To
induce similar conditions in HeLa extracts, (+/2) and (+/+) luc
mRNAs were added 8 min before viral proteases (estimated time
for the synthesis of a Luc molecule [19]) and luciferase activity was
Figure 1. Translation reinitiation of luc mRNAs in HIV-1 PR treated HeLa extracts. A) Schematic representation of (+/2), (+/+), (2/+) and
(2/2) luc mRNAs. B) HeLa extracts were programmed with 50 ng of (+/2)o r( +/+) luc mRNAs. To ensure that exogenous mRNAs are engaged in
protein synthesis machinery, viral proteases (20 ng of HIV-1 PR or 1 mg of MBP-2A
pro) were added to the lysates 8 min later. Luciferase activity was
then analyzed 1 and 3 h after the initiation of the reaction. C) eIF4GI, eIF4GII and PABP were detected by western blot. D) Luc activity was measured
at each time point. Error bars indicate standard deviations (SD) obtained from three measurements of each sample. E) Representation of the
percentage of Luc activity obtained from HeLa extracts programmed with (+/2)o r( +/+) mRNAs in presence of HIV-1 PR or MBP-2A
pro with respect to
control extracts after 1 h of incubation. SDs were obtained from three independent experiments. F) In parallel, RNAs were isolated after 1 h and
quantified by real-time RT-PCR. Relative luc RNA levels are represented. KDa, molecular weights markers. N-t, N-terminal proteolysis fragments of
eIF4GI or eIF4GII; C-t, C-terminal fragments of eIF4GI or eIF4GII; RLU, relative light units. +, HIV-1 PR-modified eIF4GII. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0007997.g001
Translation Blockage by HIV-PR
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pro
efficiently cleaved eIF4GI and eIF4GII 1 h after addition, while
PABP remained largely intact (Figure 1C). In contrast, HIV-1 PR
proteolyzed both eIF4GI and PABP at this time. As previously
observed [16], cleavage products from PABP proteolysis were not
detected in these extracts with the monoclonal antibody (Abcam)
(Figure 1C). This result suggests that these cleavage products are
unstable in lysates [16,19]. In extracts incubated with HIV-1 PR,
the electrophoretic mobility of eIF4GII was slightly increased,
probably due to cleavage at the N-terminal end of the protein
(Figure 1C). In fact, double treatment of HeLa extracts with 2A
pro
and HIV-1 PR renders an eIF4GII C-terminal polypeptide similar
to that found with 2A
pro alone, whereas the N-terminal fragment
increased its electrophoretic mobility (data not shown). This
proteolysis might not be very relevant for translation since the
functional domains in the N-terminus of eIF4GII should remain
intact [47].
After 10 min of (+/+) luc mRNA addition, a significant value of
luciferase activity was detected (Figure S1C), which is coherent
with the time predicted for the synthesis of one Luc molecule [19].
Moreover, this result suggests that luc mRNAs were engaged in
protein synthesis machinery before protease addition. Translation
of (+/2) and (+/+) luc mRNAs was severely impaired in the
extracts treated with MBP-2A
pro or HIV-1 PR, although the
substrates cleaved by each protease differ (Figure 1D). Consistent
with this, MBP protein did not inhibit translation of luc mRNAs
(data not shown). Addition of 2.5 mM saquinavir (SQ), a potent
inhibitor of HIV-1 PR, blocked the action of retroviral protease on
initiation factors, as well as on translation (Figure 1C and D).
Notably, the inhibition of Luc synthesis from (+/+) mRNA was
higher than from its (+/2) counterpart (Figure 1E). In fact, the
amount of Luc activity detected from protease treated extracts
programmed with either (+/2)o r( +/+) mRNAs was similar,
irrespective of the protease employed (Figure 1D). These data
indicate that HIV-1 PR, as occurs with MBP-2A
pro, can inhibit
cap- and poly(A)-dependent translation, reducing Luc activity to a
basal level. To test the state of luc mRNAs in HeLa extracts, these
mRNAs were quantified by real-time RT-PCR with specific
primers designed against luc sequence. The amount of both (+/2)
and (+/+) luc mRNAs was similar in each case after 1 h of
incubation, irrespective of protease addition (Figure 1F). The
results obtained using a Taqman probe designed against other
regions of luc gene sequence were similar (data not shown). Thus,
mRNA stability was not responsible for those effects. In addition,
translation of pre-existing exogenous as well as endogenous
mRNAs was strongly inhibited by HIV-1 PR in other cap-poly(A)
synergistic extracts such as non nuclease-treated Krebs-2 lysates
(Figure S2). In particular, translation of (+/+) luc mRNA was more
susceptible to protease treatment than that observed for (+/2) luc
mRNA (Figure S2A and B). Rabbit reticulocyte lysates (RRL)
treated with nuclease do not exhibit cap-poly(A) synergism
[19,48]. In contrast to the results observed in cap-poly(A)
synergistic extracts, MBP-2A
pro and HIV-1 PR blocked translation
of (+/+) and (+/2) luc mRNAs in RRL to a similar extent (data
not shown). Taking together the results obtained in the three
different cell-free systems (HeLa, Krebs-2 and RRL), we can
hypothesize that HIV-1 PR inhibits efficiently ongoing translation
of luc mRNAs by means of the specific inhibition of cap- and
poly(A)-dependent translation.
HIV-1 PR Blocks Cap- and Poly(A)-Dependent Translation
Initiation
Our next goal was aimed to determine whether PABP and
eIF4GI cleavage hamper the participation of cap and poly(A) tail
in the initiation of translation. To this end, we used a new set of luc
mRNAs that resemble the behaviour of cellular mRNAs since they
contain the 59 UTR of human globin mRNA placed before luc
ORF. These mRNAs were capped with normal cap structure
(GpppG), with a cap analog that is not able to contribute in
initiation of translation (GpppA) or were not capped. In addition,
the in vitro transcription of the template plasmid lead to the
production of a reporter with a poly(A) tail of 65A or lacking this
structure [ See Scheme of (+/G/2), (+/G/+), (A/G/2), (A/G/+),
(2/G/2) and (2/G/+) in Figure 2A].
HeLa extracts were pre-treated for 30 min with 20 ng of HIV-1
PR and replicates were recovered at this point to analyze the
integrity of initiation factors. As expected, eIF4GI and PABP were
substantially proteolyzed by HIV-1 PR at this time point (data not
shown). SQ was then added to inhibit HIV-1 PR activity while
control extracts were incubated for the entire time course with this
compound. Next, extracts were programmed with 20 ng of each
mRNAs and, finally, luciferase activity was analyzed 1 h later.
Cap (GpppG) and poly(A) structures [(+/G/2), (A/G/+) and (2/
G/+)] enhanced translation of these reporters by about 7- and 6-
to 2-fold respectively (Figure 2B, C, D and E), whereas GpppA (A/
G/2) did not contribute to initiation of translation (Figure 2C and
E). In addition, simultaneous presence of cap and poly(A) (+/G/+)
increase translatability of luc mRNAs by about 114-fold (Figure 2B
and E), leading to a translational synergism between both
structures of about 12-fold (Figure S1B). HIV-1 PR strongly
inhibited the translation of (+/G/2) luc mRNA leading to a
similar value of luciferase activity to that obtained from (A/G/2)
and (2/G/2) luc mRNAs (,6-fold inhibition) (Figure 2B and E).
In fact, translation of both (A/G/2) and (2/G/2) luc mRNAs
was not significantly affected by HIV-1 PR (Figure 2C, D and E).
Taking together, these results indicate that HIV-1 PR specifically
blocks cap-dependent initiation of translation. Similarly, transla-
tion of (A/G/+) and (2/G/+) luc mRNAs was significantly
inhibited by HIV-1 PR (,5-fold inhibition), exhibiting the same
translatability as their unpolyadenylated counterparts [(A/G/2)
and (2/G/2)] under such conditions (Figure 2C, D and E). Thus,
HIV-1 PR also blocks specifically poly(A)-dependent initiation of
translation. Finally, (+/G/+) luc mRNA exhibited the highest
translatability due to the cap-poly(A) tail synergism supported by
HeLa extracts (Figure 2B and Figure S1B). HIV-1 PR deeply
inhibited the translation of this mRNA, suggesting that this
protease is able to disrupt the cap-poly(A) synergism (Figure 2B).
To further reinforce the idea that poly(A)-dependent translation
is specifically blocked by HIV-1 PR, we compared the translat-
ability of (2/2) and (2/+) luc mRNAs (see scheme in Figure 1A)
in HeLa and Kreb-2 extracts with RRL, because nuclease-treated
RRL do not exhibit poly(A)-dependent stimulation of translation
[19,48]. Translation of luc mRNAs was enhanced 4- to 5-fold by
the presence of the poly(A) tail in HeLa and Kreb-2 extracts
(Figure 3A and B). By contrast, poly(A) tail did not contribute
substantially to initiation of translation in RRL (Figure 3C). HIV-1
PR strongly blocked translation of (2/+) luc mRNA without
affecting (2/2) translatability in HeLa and Krebs-2 extracts
(Figure 3A and B). However, HIV-1 PR was not able to hamper
translation of (2/+) luc mRNA in RRL (Figure 3C). To rule out
the possibility that mRNA stability could be the cause of the
differences between both types of cell free system, luc mRNA levels
were determined by real-time RT-PCR after 1 h of incubation in
HeLa extracts. Amounts of luc mRNAs were similar irrespective of
the presence of poly(A)-tail or HIV-1 PR addition (Figure 3D),
suggesting that their stability was the same under the different
conditions. These data support the concept that HIV-1 PR
specifically blocks poly(A)-dependent initiation of translation.
Translation Blockage by HIV-PR
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by Addition of Exogenous PABP
To determine whether the cleavage of PABP is sufficient to
inhibit poly(A)-dependent translation in HIV-1 PR-treated
extracts, we examined the effects of addition of exogenous PABP.
HeLa extracts were incubated with 10 ng HIV-1 PR for 30 min,
because this treatment induces the total cleavage of PABP while
eIF4GI is only partially proteolyzed (Figure 4A). The polyclonal
antibody against PABP detected weak PABP-derived cleavage
products of about 50 and 40 KDa, which are coherent with
previous findings [16]. SQ was then added to block protease
activity and extracts were programmed with 20 ng of (2/G/+),
(+/2), (+/+), (2/+)o r( 2/2)luc mRNAs (Figure 1A and 2A).
Simultaneously, extracts were supplemented or not with 25 ng of
GST-PABP1 or GST alone as a control and luciferase activity was
measured 1 h later. Luciferase activity decreased strongly (80–
90%) in extracts treated with HIV-1 PR programmed with either
type of mRNAs (Figure 4B, C, D and E, third bar), but not in the
case of (2/2) luc mRNA. These data indicate that cap- as well as
poly(A)-dependent translation was inhibited by the retroviral
protease as observed in Figure 2. GST addition did not
substantially affect the translatability of luc mRNAs in HIV-1-
treated extracts (Figure 4B, C, D and E, sixth bar). Addition of
GST-PABP1 did not prevent the effect of HIV-1 PR on (+/2) luc
mRNA translation, pointing to the idea that PABP does not
counteract the inhibition of translation of capped mRNAs without
poly(A) tail induced by the retroviral protease (Figure 4C, fourth
bar). Notably, 25 ng GST-PABP1 moderately but significantly
restored Luc synthesis from (2/G/+) and (2/+) luc mRNA in
HIV-1 PR treated extracts (Figure 4B and E, fourth bar). These
results further support the idea that PABP cleavage inhibits
poly(A)-dependent translation. Finally, GST-PABP addition
slightly but significantly recovered translation of (+/+) luc mRNA
(Figure 4D, fourth bar). This result is coherent with the idea that
eIF4GI cleavage also blocks cap-dependent translation, most
probably disrupting the synergism between cap and poly(A) tail.
SQ prevented all the effects induced by HIV-1 PR when added at
the beginning of this reaction (Figure 4B, C, D and E second bar).
Therefore, exogenous PABP specifically re-establishes poly(A)-
dependent translation to some extent in lysates incubated with
HIV-1 PR. Therefore, our data indicate that exogenous PABP is
able to partially rescue the translation driven by poly(A) tail when
endogenous PABP is cleaved by HIV-1 PR.
Effects of HIV-1 PR on Translation of mRNAs Containing
IRES and Poly(A) Tail
Translation of picornavirus mRNAs is stimulated by poly(A) tail
to a similar extent to that observed with capped host mRNAs
[43,49,50]. Nevertheless, hydrolysis of eIF4G by PV 2A
pro
stimulates encephalomyocarditis virus (EMCV) IRES-driven trans-
lation despite the impairment of poly(A)-dependent translation
[43,49,50]. Although the contribution of eIF4G cleavage by PV
2A
pro to translation of picornavirus mRNAs has been extensively
studied, the repercussion of PABP hydrolysis on protein synthesis
directed by IRES remains unexplored. To this end, HeLa extracts
were pre-treated with HIV-1 PR or MBP-2A
pro as a control. After
30 min, extracts were programmed with unpolyadenylated EMCV
IRES-containing luc mRNA (E/2) or its polyadenylated counter-
part (E/+) (Figure 5A). The poly(A) tail increased Luc expression
from EMCV-containing mRNAs by about 4–5 fold in HeLa
extracts (Figure 5B), whereas almost no stimulation appeared in
RRL (data not shown). Translation of (E/2) luc mRNAs increased
after HIV-1 PR treatment as compared to control extracts
Figure 2. Analysis of cap- and poly(A)-dependent translation of
luc mRNAs in HIV-1 PR treated HeLa extracts. HeLa extracts were
treated with 20 ng HIV-1 PR. After 30 min, SQ 2.5 mM was added to the
lysate. Simultaneously, extracts were programmed with 20 ng (+/G2),
(+/G/+), (A/G/2), (A/G/+), (2/G/2)o r( 2/G/+) luc mRNAs, which are
schematized in panel (A). As a control, a replicate was incubated with
2.5 mM SQ from the beginning of the reaction (grey bars). B, C and D)
Luc activity was analyzed 30 min later and the data obtained from
translation of each mRNA were plotted. E) Relative Luc activity obtained
from each mRNA in presence and absence of HIV-1 PR was represented.
S.D. were obtained from three independent experiments. *P,0.05;
**P,0.01.
doi:10.1371/journal.pone.0007997.g002
Translation Blockage by HIV-PR
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IRES-driven translation, at least when eIF4GI is also proteolyzed
(Figure 5C). Notably, translatability of (E/+) luc mRNA was similar
in presence or absence of HIV-1 PR. This result suggests that
enhancement of EMCV IRES-driven translation by HIV-1 PR is
sufficient to replace poly(A)-dependent translation. A similar result
was observed using another mRNA bearing PV IRES (data not
shown). Thus, stimulation of IRES-driven Luc synthesis promoted
by eIF4GI cleavage counteracts the inhibition of poly(A)-dependent
translation induced by PABP proteolysis. Addition of MBP-2A
pro to
HeLa extracts provoked substantial hydrolysis of both forms of
eIF4G, while PABP remained intact (Figure 5C). In MBP-2A
pro-
treated extracts, translation of (E/2) or (E/+) luc mRNAs was
strongly stimulated (Figure 5B, grey bars). Nevertheless, the
translational enhancement induced by PV 2A
pro was lower with
(E/+) than with (E/2) luc mRNAs (5-fold versus 18-fold,
respectively). Luc activity from MBP-2A
pro treated extracts was
similar in both cases regardless of whether a poly(A) tail was present
(Figure 5B, grey bars). Translation stimulation conferred by poly(A)
tail is probably abrogated in MBP-2A
pro treated lysates by cleavage
of eIF4GI and eIF4GII and compensated by the increase of IRES-
driven translation. To determine the amount of IRES-containing
luc mRNAs in these extracts, real-time RT-PCR with specific
primers against luc sequence was carried out. Of interest, levels of
luc mRNA were similar in each case after incubating for 1 h in
HeLa extracts (Figure 5D). These results reflect that the differential
enhancement on IRES-driven translation observed in extracts
treatedwithHIV-1 PR or MBP-2A
pro wasnot dueto changes in the
stability of luc mRNAs.
Impact of HIV-1 PR on the Translation of HIV-1 Genomic
mRNA
HIV-1 genomic mRNA bears an IRES that comprises its 59
UTR and part of the coding sequence [12,13]. However, the
exact mechanism by which this mRNA is translated in infected
cells is poorly understood. There are at least three viral factors
that could influence the translatability of HIV-1 mRNAs: HIV-1
PR, Gag polyprotein and Rev [9,47,51,52,53]. To determine
whether translation of HIV-1 genomic (HIV-1g) mRNA (scheme
in Figure 6A) takes place when PABP and eIF4GI have been
cleaved by HIV-1 PR, HeLa extracts were treated with this
protease for 30 min. SQ was then added to the reaction mixture
to inhibit the retroviral protease. Pre-treated extracts were
programmed with different amounts of HIV-1g mRNA tran-
scribed, capped and polyadenylated in vitro. As a control,
translation of (+/+)a n d( E / +) luc mRNAs was also assayed. After
incubating for 1 h, labelled proteins were analyzed by SDS-
PAGE, followed by autoradiography. Treatment with 20 ng
HIV-1 PR leads to cleavage of eIF4GI and PABP (Figure 6B). As
expected, Luc synthesis from (+/+) mRNA was potently inhibited
by HIV-1 PR pre-treatment, whereas translation of (E/+)l u c
mRNA was not affected under these conditions (Figure 6C) as
observed above in Figure 5B. Synthesis of Gag (p55) was detected
in extracts programmed with 50 ng HIV-1 mRNA, but optimal
translation was achieved with 100 ng (Figure 6D). Synthesis of
Gag-Pol was not detected, probably because this polyprotein is
synthesized by an inefficient mechanism involving ribosomal
frameshifting [54] (data not shown). Pre-treatment with 20 ng of
HIV-1 PR did not affect Gag production irrespective of the dose
Figure 3. Analysis of poly(A)-dependent translation of luc mRNAs in HIV-1 PR treated HeLa extracts. HeLa (A), Krebs-2 (B) extracts or RRL
(C) were treated with 20 ng HIV-1 PR for 30 min. Next, SQ 2.5 mM was added to the translation reaction to inhibit the protease activity. At this time
point, extracts were programmed with 200 ng (2/2)o r( 2/+) mRNAs. As a control, a replicate reaction was incubated with 2.5 mM SQ from the
beginning of incubation (grey bars). Luc activity was analyzed 30 min later and relative Luc activity from two independent experiments was
represented. D) In parallel, RNAs were isolated from HeLa extracts and the amount of luc mRNA was determined by real-time RT-PCR. Relative luc
mRNA levels were then represented. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0007997.g003
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HIV-1g mRNA can be translated when eIF4GI and PABP are
cleaved by HIV-1 PR.
To further reinforce this observation HeLa extracts were treated
with increasing amounts of HIV-1 PR. After 30 min of pre-
incubation, 50 or 100 ng HIV-1g mRNA were added to the
translation mixture and protein synthesis was analyzed by
autoradiography 1h later (Figure 6E). Translation of (+/+) luc
mRNA was partially inhibited after incubation with 5 ng HIV-1
PR, and was almost completely blocked with 20 and 50 ng of the
retroviral protease (Figure 6E and F). Notably, Gag polyprotein
was synthesized from HIV-1g after pre-incubation with 5 or 20 ng
HIV-1 PR in a similar amount than control samples, although an
inhibition was observed (about 50%) when 50 ng of this protease
was used (Figure 6E and F). The behaviour of HIV-1g mRNA in
presence of HIV-1 PR was the same irrespective of the dose of
mRNA used (Figure 6E). These results suggest that HIV-1g
mRNA translation is more resistant to HIV-1 activity than cellular
capped and polyadenylated mRNAs.
Discussion
Host mRNAs are capped and polyadenylated by the cellular
machinery. These structures are essential for mRNAs to be
recognized by the protein synthesis machinery. Cleavage of
translation initiation factors is a mechanism employed by a
number of animal viruses to modulate host and viral protein
synthesis [3]. In this regard, different viruses such as retroviruses,
picornaviruses and caliciviruses have evolved similar strategies to
interfere with cap and poly(A)-tail recognition by initiation factors,
thereby maximizing the competitiveness of their own mRNAs for
the translational machinery [2,3]. eIF4GI, eIF4GII and PABP are
targets for viral proteases in mammalian cells infected with some
virus species, impairing the canonical initiation of translation
[3,9,10,17,18,55,56,57,58]. Our present findings indicate that
HIV-1 PR strongly inhibits translation of cellular mRNAs engaged
with protein synthesis machinery. Furthermore, this protease
blocks translation of polyadenylated mRNAs to a greater extent
than their unpolyadenylated counterparts. These results have been
Figure 4. Restoration of poly(A)-dependent translation by addition of recombinant GST-PABP1 in HeLa extracts treated with HIV-1
PR. HeLa lysates were incubated with or without 10 ng HIV-1 PR. The integrity of eIF4GI and PABP was determined by western blotting (A). After
30 min, 20 ng (2/G/+) (B), (+/2) (C), (+/+) (D), (2/+) (E) or (2/2) (F) luc mRNAs and 2.5 mM SQ was added to the extract. In a control reaction, SQ was
present throughout the time course (bar 2). The extracts indicated were then supplemented with 25 ng GST-PABP1 or GST. Luc activity was measured
1 h later. The relative Luc activity obtained from (2/G/+) (B), (+/2) (C), (+/+) (D), (2/+) (E) or (2/2) (F) luc mRNAs was represented. *P,0.05;
**P,0.01; ns, non-significant; C.p., putative cleavage product.
doi:10.1371/journal.pone.0007997.g004
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lysates), revealing that these proteases are able to abrogate
synergism between the cap and poly(A) tail. In particular,
translation of a capped and polyadenylated luc mRNA in HIV-1
PR-treated extracts decreased to the translational level of an
uncapped and unpolyadenylated luc mRNA, suggesting that the
cap and poly(A) tail do not contribute to translation when the
protein synthesis machinery is modified by this viral protease.
Cleavage of both eIF4GI and eIF4GII is required for PV 2A
pro to
inhibit completely the initiation of translation in HeLa cells [43].
Indeed, eIF4GI proteolysis alone is insufficient to block endogenous
protein synthesis [43,59]. These previous reports point to the idea
that, apart from eIF4GI, HIV-1 PR may cleave an additional
translationfactorto abolish protein synthesis.We recently described
that HIV-1 PR efficiently bisects PABP [16], as occurs with PV
3C
pro [18]. Both proteases separate NTD and CTD domains of
PABP, but the retroviral protease carries out an additional cleavage
within RRM3 [16]. As occurs in the case of 3C
pro [19], HIV-1 PR
efficiently inhibits ongoing cellular translation, perhaps due to
eIF4GI and PABP cleavage since both factor are essential to
circularize mRNAs [30]. In addition, HIV-1 PR specifically blocks
poly(A)-dependent initiation of translation. Thus, luciferase synthe-
sis from an uncapped and polyadenylated mRNA is impaired in
HIV-1 PR treated HeLa and Krebs-2 extracts, whereas a weak
effect was observed on translation of an uncapped and unpolyade-
nylated luc mRNA. Moreover, HIV-1 PR has no apparent effect on
Luc synthesis from both types of uncapped mRNAs in RRL, that
does not exhibit poly(A)-dependent stimulation of translation. In
addition, incubation with exogenous GST-PABP1 partially restores
poly(A)-dependent translation in HIV-1 PR treated HeLa extracts.
Probably, translation of polyadenylated mRNAs is not completely
restored under our experimental conditions because eIF4GI is
partially proteolyzed, and this proteolysis impedes the interaction
between eIF4GI and PABP. Thus, simultaneous cleavage of eIF4GI
and PABP might cooperate to block efficiently poly(A)-dependent
translation underlying a double-target mechanism to inhibit host
translation.
Kahvejian et al. reported that a recombinant PABP containing
only the NTD portion is sufficient to significantly restore poly(A)-
dependent translation in PABP depleted Krebs-2 extracts, since
NTD contains the domains required to circularize the mRNA:
RRMs and eIF4G interacting site [30]. Nevertheless, under their
experimental conditions CTD was not present. CTD, separated by
HIV-1 PR, could reduce the availability of translation factors such
as eIF4B, Paip-1 or eRF3. Alternatively, lack of CTD could inhibit
the oligomerization of PABP on poly(A) tail [3,20]. HIV-1 PR also
cleaves PABP within RRM3, rendering a product containing
RRM1-2 [16]. A recombinant PABP protein that only contains
RRM1-2 has little capacity to restore poly(A)-dependent transla-
tion in PABP-depleted Krebs-2 extracts [30]. In addition, cleavage
products derived from PABP proteolysis by HIV-1 PR seem to be
unstable in cultured cells or in cell extracts [16]. Therefore, HIV-1
Figure 5. Effects of HIV-1 PR on translation of polyadenylated EMCV-IRES containing mRNAs in HeLa extracts. HeLa extracts were
treated with 20 ng of HIV-1 PR or 1 mg of MBP-2A
pro for 30 min. HeLa extracts were then programmed with 50 ng of (E/2) or (E/+) luc mRNAs. The
samples were analyzed 1 h after the addition of luc mRNAs. A) Schematic representation of (E/2) and (E/+) luc mRNAs. B) Relative amounts of Luc
activity. SDs were determined from three measurements of two independent experiments. *P,0.05; **P,0.01; ns, non-significant. C) eIF4GI, eIF4GII
and PABP were analyzed by western blot. D) In parallel, after 1 h of translation reaction, total RNA was isolated from each sample and quantified by
real-time RT-PCR. The relative levels of luciferase mRNAs were plotted.
doi:10.1371/journal.pone.0007997.g005
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suggest that proteolysis of eIF4GI and PABP by HIV-1 PR blocks
host protein synthesis, as occurs when eIF4GI and eIF4GII are
cleaved by PV-2A
pro. In this regard, PV-3C
pro provoked a potent
inhibition of ongoing protein synthesis by PABP hydrolysis. This
translational blockade increases when PV 3C
pro is combined with
PV 2A
pro, leading to both PABP and eIF4G inactivation [19].
Therefore, HIV-1 PR possesses some 2A
pro and 3C
pro activities,
targeting both eIF4G and PABP [9,16].
According to a recent report, PABP cleavage by 3C
pro inhibits
PV IRES-driven translation [60]. It has been proposed that PABP
cleavage, together with hydrolysis of other RNA-binding proteins,
such as polypyrimidine tract-binding protein (PTB) and other
PABP-associated proteins, are implicated in viral RNA switching
from translation to replication [58,60,61,62]. Translation of
picornavirus IRES-containing mRNAs are stimulated by poly(A)
tail, as occurs with host mRNAs. However, hydrolysis of both
eIF4G and PABP takes place in PV-infected cells, suggesting that
cap- and poly(A)-dependent translation should be impaired for
both viral and host mRNAs. Cleavage of eIF4GI by HIV-1 PR did
not enhance EMCV and PV IRES-driven translation to a level
comparable to that found after 2A
pro incubation, although it was
sufficient to replace IRES poly(A) tail synergism in HeLa extracts.
In agreement with this data, 2A
pro partially restores PV IRES-
driven translation in HeLa extracts treated with 3C
pro [60].
Therefore, HIV-1 PR resembles to some extent the action of 2A
pro
and 3C
pro on picornavirus IRES-driven translation, perhaps due
to simultaneous cleavage of eIF4GI and PABP.
Figure 6. Translation of HIV-1g mRNA in presence of HIV-1 PR. A) Schematic representation of HIV-1g mRNA, indicating the structures of the
leader sequence and the open reading frames encoded. B) HeLa extracts were programmed with different doses of HIV-1 PR (5, 20 and 50 ng). eIF4GI
and PABP were analyzed by western blot after 30 min of incubation. C) HeLa extracts supplemented with [
35S]Met-[
35S]Cys were pre-incubated with
20 ng HIV-1 PR for 30 min. Extracts were then incubated with 2.5 mM SQ and programmed with 100 ng (+/+) or (E/+) luc mRNAs. Translation reaction
was stopped after 1 h and protein synthesis was analyzed by SDS-PAGE followed by fluorography and autoradiography. D) HeLa extracts
supplemented with [
35S]Met-[
35S]Cys were pre-incubated with 20 ng HIV-1 PR for 30 min. Extracts were then incubated with 2.5 mM SQ and
subsequently programmed with 20, 50 100 or 200 ng HIV-1g mRNA or 100 ng (+/+) luc mRNA. Translation reaction was stopped after 1 h and protein
synthesis was analyzed by SDS-PAGE followed by fluorography and autoradiography. The data shown in this figure is a representative experiment of
a set of three independent experiments. E) HeLa extracts supplemented with [
35S]Met-Cys were pre-incubated with 5, 20 or 50 ng HIV-1 PR for
30 min. 2.5 mM SQ was added to the reaction mixture and next, extracts were programmed with 50 or 100 ng HIV-1g mRNA or 100 ng (+/+) luc
mRNA. Translation reaction was stopped after 1 h and protein synthesis was analyzed by SDS-PAGE followed by fluorography and autoradiography.
The data shown is a representative experiment of a set of two independent experiments. F) Comparative representation of Gag or Luc synthesis after
pre-incubation with increasing amounts of HIV-1 PR (5, 20 and 50 ng). SD, were obtained from two independent experiments. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0007997.g006
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PLoS ONE | www.plosone.org 9 November 2009 | Volume 4 | Issue 11 | e7997Early findings indicated that HIV-1 mRNAs are translated by a
cap-dependent mechanism as occurs with most cellular mRNAs
[63]. However, recent reports have proposed that HIV-1 mRNAs
as well as mRNAs from other lentiviruses could be translated by
internal initiation [12,13,14,15,47,64]. In addition, a dual
mechanism (cap-dependent and cap-independent) translation has
been proposed for HIV-1 mRNAs [65]. Leader sequences from
HIV-1 mRNAs are long and highly structured, rendering HIV-1
mRNAs a poor substrate for ribosome scanning and cap-
dependent translation. In addition, the leader sequence of HIV-
1 and HIV-2 contains encapsidation signals, which are recognized
by Gag polyprotein. Oligomerization of Gag polyprotein onto
HIV-1 and HIV-2 leader sequence may inhibit the scanning of the
initiation complex [51,64]. Thus, internal initiation could be a
plausible mechanism for direct recruitment of ribosomes to the
initiation AUG during HIV infection. Consistent with this idea,
our present findings reveal that Gag polyprotein is synthesized in
spite of eIF4GI and PABP cleavage by HIV-1 PR from an
authentic HIV-1g mRNA. These results indicate that HIV-1g
mRNA can be translated when cap- and poly(A)-dependent
translation is arrested, supporting the concept that translation
initiation of this mRNA proceeds by a non-canonical mechanism.
We previously described that the translation of an unpolyadeny-
lated luc reporter mRNA bearing the HIV-1 leader sequence (cap-
L59HIV-Luc mRNA) is inhibited by HIV-1 PR in HeLa extracts,
whereas Gag synthesis from an mRNA that also contains gag gene
(cap-L59GAG-PR mRNA) is stimulated under these conditions
[9,47]. In this regard, we analyze here the translatability of an
authentic polyadenylated HIV-1 genomic mRNA in presence of
the retroviral protease. The data presented here using HIV-1g
mRNA agree well with the experiment carried out with cap-
L59GAG-PR mRNA in HeLa extracts [9,47], supporting the idea
that both mRNAs are efficiently translated in presence of HIV-1
PR. Further efforts are necessary to determine the exact molecular
mechanism by which HIV-1 mRNAs are engaged in the protein
synthesis machinery in HIV-1 infected cells.
Supporting Information
Figure S1 Translation of reporter luc mRNAs in HeLa extracts.
A)HeLaextractswereprogrammedwith50 ng(+/2),(+/+),(2/2)
and (2/+) luc mRNAs. 1 h later luciferase activity was measured in
each case and relative luciferase activity from three independent
experiments was plotted. B) HeLa extracts were programmed with
50 ng (+/G/2), (+/G/+), (2/G/2)a n d( 2/G/+) luc mRNAs. 1 h
later luciferase activity was measured in each case and relative
luciferase activity from three independent experiments was plotted.
C) HeLa extracts were programmed with 50 ng (+/+)m R N Aa n d
luciferase activity was analyzed after 5, 10 and 15 min. Error bars
represent SD from two independent experiments.
Found at: doi:10.1371/journal.pone.0007997.s001 (0.20 MB
JPG)
Figure S2 Translation of exogenous and endogenous luc
mRNAs in HIV-1 PR treated Kreb-2 extracts. Non-nuclease-
treated Kreb-2 extracts supplemented with [35S]Met-[35S]Cys/
ml were programmed with 50 ng of (+/2)o r( +/+) luc mRNAs.
After 8 min, 20 ng of HIV-1 PR were added to the lysates. The
samples were analyzed 1 and 3 h after the initiation of the
reaction. A) Luc activity at each time point was measured and
plotted. Error bars indicate standard deviations obtained from
three measurements of each sample. B) Relative quantification of
the Luc activity obtained from HeLa extracts programmed with
(+/2)o r( +/+) mRNAs in presence of HIV-1 PR with respect to
control extracts after 1 h of incubation. SDs were obtained from
three independent experiments. C) eIF4GI, eIF4GII and PABP
were detected by western blot. D) Endogenous protein synthesis
was analyzed by SDS-PAGE followed by fluorography and
autoradiography.
Found at: doi:10.1371/journal.pone.0007997.s002 (0.24 MB
JPG)
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